Why the study?
Does oral flecainide improve symptoms in patients with symptomatic arrhythmias and normal cardiac function?
Population
38 patients with symptomatic arrhythmias and normal cardiac function (76% paroxysmal atrial fibrillation)
Design
Cohort
Follow-up
mean 25 months (range 8 to 50 months)
Authors
Loading...
May support symptom relief with flecainide in select patients; leaves open confirmation via randomized trials.
Does oral flecainide improve symptoms in patients with symptomatic arrhythmias and normal cardiac function?
Oral flecainide is effective for symptomatic arrhythmias in patients with normal cardiac function, but requires monitoring for proarrhythmic adverse effects.
Nakazato et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: